HighTower Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
CCA
AWM
KF
OIA
KAS
WIM
MWM
GSWA
LA
HighTower Advisors's BTAL Position: Q2 2026 in Review
HighTower Advisors reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 42% in Q2 2026, selling an estimated $7.08M and leaving 797,480 shares worth $8.89M. The position accounts for 0.01% of the portfolio, ranked #980.
HighTower Advisors first reported a position in BTAL in Q3 2022 and has held it in 9 quarters since. The position peaked at $19.3M in Q1 2026. 48 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- HighTower Advisors held 797,480 shares of AGF US Market Neutral Anti-Beta Fund worth $8.89M as of Q2 2026.
- HighTower Advisors sold 582,088 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $7.08M.
- AGF US Market Neutral Anti-Beta Fund made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #980 holding.
- HighTower Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and has held it in 9 quarters since.
- HighTower Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $19.3M in Q1 2026.
- 48 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.